Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 3/20 | 0.47 |
| ▸ | CES1 | P23141 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | SCN1A | P35498 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.47 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.47 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14981917 | 0.98 | NAAA (0.59) | NAAALMNATSHRCES2CES1 | |
| SCHEMBL14981922 | 0.98 | NAAA (0.59) | NAAALMNATSHRCES2CES1 | |
| SCHEMBL18196734 | 0.98 | NAAA (0.59) | NAAALMNATSHRCES2CES1 | |
| SCHEMBL11503257 | 0.98 | NAAA (0.59) | NAAALMNATSHRCES2CES1 | |
| SCHEMBL16487021 | 0.97 | NAAA (0.58) | NAAALMNATSHRCES2CES1 | |
| SCHEMBL3492807 | 0.95 | LMNA (0.51) | NAAALMNATSHRCES2CES1 | |
| SCHEMBL28876438 | 0.91 | MGLL (0.51) | NAAALMNATSHRALDH1A1MAPT | |
| SCHEMBL21599106 | 0.90 | MGLL (0.54) | NAAALMNATSHRALDH1A1MAPT | |
| SCHEMBL21599094 | 0.90 | MGLL (0.54) | NAAALMNATSHRALDH1A1MAPT | |
| SCHEMBL10904247 | 0.90 | KMT2A (0.53) | NAAALMNATSHRCES1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0923537-A1 | PROCESS FOR THE PREPARATION OF CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 1999-06-23 | — | — | EP | claimed |
| WO-1998008805-A1 | PROCESS FOR THE PREPARATION OF CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 1998-03-05 | — | — | WO | claimed |
| CN-117821978-A | Preparation method and application method of corrosion inhibitor for improving metal rust prevention capability | 马鞍山钢铁股份有限公司 | 2024-04-05 | — | — | CN | disclosed |
| US-8735622-B2 | Histone demethylase inhibitors and methods for using the same | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2014-05-27 | — | — | US | disclosed |
| US-20130137720-A1 | HISTONE DEMETHYLASE INHIBITORS AND METHODS FOR USING THE SAME | The Regents of the University of Colorado, a body corporated (US) | 2013-05-30 | — | — | US | disclosed |
| US-4207330-A | Method for treating hyperglycemia in mammals using arylamino benzoic acids | THE DOW CHEMICAL COMPANY (US) | 1980-06-10 | — | — | US | disclosed |
| US-4143151-A | METHOD FOR TREATING HYPERGLYCEMIA IN MAMMALS USING ARYLAMINO BENZOIC ACIDS | THE DOW CHEMICAL COMPANY (US) | 1979-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130137720-A1 | HISTONE DEMETHYLASE INHIBITORS AND METHODS FOR USING THE SAME | KDM1A, KDM3A, KDM7A | NAAA 325/4885LMNA 641/4885TSHR 4764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.